Ceftazidime
NDC Package 65862-178-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ceftazidime is used to treat a wide variety of bacterial infections. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 65862-178 and is authorized under FDA application ANDA065481.

Identification & Billing

NDC Package Code
65862-178-05
Package Description
10 VIAL in 1 BOX / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code
65862-178
11-Digit Billing Format
65862017805

Clinical Specifications

Proprietary Name
Ceftazidime
Dosage Form
-
Usage Information
Ceftazidime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Aurobindo Pharma Limited
FDA Application #
ANDA065481
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-28-2010
End Marketing Date
06-30-2012
Listing Expiration
06-30-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65862-178-05 identifies a specific commercial package of 10 vial in 1 box / 1 injection, powder, for solution in 1 vial of Ceftazidime, labeled by Aurobindo Pharma Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aurobindo Pharma Limited on May 28, 2010. The current certification is valid through June 30, 2012.

What are the primary indications for this medication?

Ceftazidime is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

How is this Aurobindo Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65862017805. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65862-178-05
11-Digit CMS (5-4-2)
65862-0178-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.